These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23549433)

  • 1. A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
    Huang J; Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Sato S; Yamasaki R; Kira J;
    Mult Scler; 2013 Nov; 19(13):1696-703. PubMed ID: 23549433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
    Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis.
    Brum DG; Barreira AA; dos Santos AC; Kaimen-Maciel DR; Matiello M; Costa RM; Deghaide NH; Costa LS; Louzada-Junior P; Diniz PR; Comini-Frota ER; Mendes-Junior CT; Donadi EA
    Mult Scler; 2010 Jan; 16(1):21-9. PubMed ID: 19995845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.
    Brill L; Mandel M; Karussis D; Petrou P; Miller K; Ben-Hur T; Karni A; Paltiel O; Israel S; Vaknin-Dembinsky A
    J Neuroimmunol; 2016 Apr; 293():65-70. PubMed ID: 27049564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HLA-DRB1 typing in Caucasians patients with neuromyelitis optica].
    Blanco Y; Ercilla-González G; Llufriu S; Casanova-Estruch B; Magraner MJ; Ramió-Torrentá L; Mendibe-Bilbao MM; Uclés-Sánchez AJ; Casado-Chocán JL; López de Munain A; Ramo-Tello C; Santos-Lasaosa S; Fernández-Bolaños Porras R; Segura-Bruna N; Sepulveda-Gázquez M; Villoslada P; Graus F; Saiz A
    Rev Neurol; 2011 Aug; 53(3):146-52. PubMed ID: 21748712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A NOTCH4 association with multiple sclerosis is secondary to HLA-DR*1501.
    Duvefelt K; Anderson M; Fogdell-Hahn A; Hillert J
    Tissue Antigens; 2004 Jan; 63(1):13-20. PubMed ID: 14651518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data.
    Watanabe M; Nakamura Y; Sato S; Niino M; Fukaura H; Tanaka M; Ochi H; Kanda T; Takeshita Y; Yokota T; Nishida Y; Matsui M; Nagayama S; Kusunoki S; Miyamoto K; Mizuno M; Kawachi I; Saji E; Ohashi T; Shimohama S; Hisahara S; Nishiyama K; Iizuka T; Nakatsuji Y; Okuno T; Ochi K; Suzumura A; Yamamoto K; Kawano Y; Tsuji S; Hirata M; Sakate R; Kimura T; Shimizu Y; Nagaishi A; Okada K; Hayashi F; Sakoda A; Masaki K; Shinoda K; Isobe N; Matsushita T; Kira JI
    Sci Rep; 2021 Jan; 11(1):607. PubMed ID: 33436735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic factors for susceptibility to and manifestations of neuromyelitis optica.
    Matsushita T; Masaki K; Isobe N; Sato S; Yamamoto K; Nakamura Y; Watanabe M; Suenaga T; Kira JI;
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2082-2093. PubMed ID: 32979043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
    Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
    Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
    J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA DRB1-DQB1 Haplotypes with the Risk for Neuromyelitis Optica among South Indians.
    Kanikannan MA; Kathgave R; Yareeda S; Katkam SK; Kumaraswamy K; Kutala VK
    Neurol India; 2022; 70(4):1481-1486. PubMed ID: 36076647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors.
    Fukazawa T; Yamasaki K; Ito H; Kikuchi S; Minohara M; Horiuchi I; Tsukishima E; Sasaki H; Hamada T; Nishimura Y; Tashiro K; Kira J
    Tissue Antigens; 2000 Mar; 55(3):199-205. PubMed ID: 10777094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population.
    Deschamps R; Paturel L; Jeannin S; Chausson N; Olindo S; Béra O; Bellance R; Smadja D; Césaire D; Cabre P
    Mult Scler; 2011 Jan; 17(1):24-31. PubMed ID: 20861181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HLA DRB1*03:01 allele is associated with NMO regardless of the NMO-IgG status in Brazilian patients from Rio de Janeiro.
    Alvarenga MP; Fernandez O; Leyva L; Campanella L; Vasconcelos CF; Alvarenga M; Papais Alvarenga RM
    J Neuroimmunol; 2017 Sep; 310():1-7. PubMed ID: 28778431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DRB1*15:01 and multiple sclerosis: a female association?
    Irizar H; Muñoz-Culla M; Zuriarrain O; Goyenechea E; Castillo-Triviño T; Prada A; Saenz-Cuesta M; De Juan D; Lopez de Munain A; Olascoaga J; Otaegui D
    Mult Scler; 2012 May; 18(5):569-77. PubMed ID: 22127897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
    Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
    J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
    Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.